Pharmacokinetics and Safety of Oral Doses of Meloxicam in Foals Less Than Six Weeks of Age

Sharanne Raidal; Joe Pippia; Glenys Noble

Pharmacokinetics and Safety of Oral Doses of Meloxicam in Foals Less Than Six Weeks of Age

Sharanne Raidal, Joe Pippia, Glenys Noble

Animal and Veterinary Sciences

Research output: Other contribution to conference › Abstract › peer-review

Abstract

Meloxicam is a potent non-steroidal anti-inflammatory drug (NSAID) that has been shown to be an effective analagesic and anti-inflammatory in adult horses at a dose rate of 0.6 mg/kg, PO, q 24 h. Pharmacokinetics and safety of this drug have not been reported in foals 6 wk of age.

Original language	English
Pages	33-33
Number of pages	1
Publication status	Published - 2009
Event	American Association of Equine Practitioners’ 55th Annual Convention - Mandalay Bay Convention Center, Las Vegas, United States Duration: 05 Dec 2009 → 09 Dec 2009

Conference

Conference	American Association of Equine Practitioners’ 55th Annual Convention
Country	United States
City	Las Vegas
Period	05/12/09 → 09/12/09

Fingerprint Dive into the research topics of 'Pharmacokinetics and Safety of Oral Doses of Meloxicam in Foals Less Than Six Weeks of Age'. Together they form a unique fingerprint.

Cite this

@conference{8bf4eee2600c4952a4ab2b926915da9b,

title = "Pharmacokinetics and Safety of Oral Doses of Meloxicam in Foals Less Than Six Weeks of Age",

abstract = "Meloxicam is a potent non-steroidal anti-inflammatory drug (NSAID) that has been shown to be an effective analagesic and anti-inflammatory in adult horses at a dose rate of 0.6 mg/kg, PO, q 24 h. Pharmacokinetics and safety of this drug have not been reported in foals 6 wk of age.",

author = "Sharanne Raidal and Joe Pippia and Glenys Noble",

year = "2009",

language = "English",

pages = "33--33",

note = "American Association of Equine Practitioners{\textquoteright} 55th Annual Convention ; Conference date: 05-12-2009 Through 09-12-2009",

}

TY - CONF

T1 - Pharmacokinetics and Safety of Oral Doses of Meloxicam in Foals Less Than Six Weeks of Age

AU - Raidal, Sharanne

AU - Pippia, Joe

AU - Noble, Glenys

PY - 2009

Y1 - 2009

N2 - Meloxicam is a potent non-steroidal anti-inflammatory drug (NSAID) that has been shown to be an effective analagesic and anti-inflammatory in adult horses at a dose rate of 0.6 mg/kg, PO, q 24 h. Pharmacokinetics and safety of this drug have not been reported in foals 6 wk of age.

AB - Meloxicam is a potent non-steroidal anti-inflammatory drug (NSAID) that has been shown to be an effective analagesic and anti-inflammatory in adult horses at a dose rate of 0.6 mg/kg, PO, q 24 h. Pharmacokinetics and safety of this drug have not been reported in foals 6 wk of age.

M3 - Abstract

SP - 33

EP - 33

T2 - American Association of Equine Practitioners’ 55th Annual Convention

Y2 - 5 December 2009 through 9 December 2009

ER -